0.2% Betamethasone Sodium Phosphate: A Multicenter, Randomized, Double-Masked Study to Compare Its Ocular Safety, Tolerability, and Efficacy to Vehicle in Cataract Surgery Subjects

Kamran Hosseini, Subba Gollamudi, Harvey Reiser, Tom Walters, Richard L Lindstrom

Open source

DOI
10.2147/opth.s419857
Published
2023-08
Container
Clinical Ophthalmology
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/opth.s419857,
  title = {0.2\% Betamethasone Sodium Phosphate: A Multicenter, Randomized, Double-Masked Study to Compare Its Ocular Safety, Tolerability, and Efficacy to Vehicle in Cataract Surgery Subjects},
  author = {Kamran Hosseini and Subba Gollamudi and Harvey Reiser and Tom Walters and Richard L Lindstrom},
  year = {2023},
  journal = {Clinical Ophthalmology},
  doi = {10.2147/opth.s419857},
  url = {https://doi.org/10.2147/opth.s419857}
}

RIS

TY  - JOUR
TI  - 0.2% Betamethasone Sodium Phosphate: A Multicenter, Randomized, Double-Masked Study to Compare Its Ocular Safety, Tolerability, and Efficacy to Vehicle in Cataract Surgery Subjects
AU  - Kamran Hosseini
AU  - Subba Gollamudi
AU  - Harvey Reiser
AU  - Tom Walters
AU  - Richard L Lindstrom
PY  - 2023
JO  - Clinical Ophthalmology
DO  - 10.2147/opth.s419857
UR  - https://doi.org/10.2147/opth.s419857
ER  - 

APA

Hosseini, K., Gollamudi, S., Reiser, H., Walters, T., & Lindstrom, R. L. (2023). 0.2% Betamethasone Sodium Phosphate: A Multicenter, Randomized, Double-Masked Study to Compare Its Ocular Safety, Tolerability, and Efficacy to Vehicle in Cataract Surgery Subjects. Clinical Ophthalmology. https://doi.org/10.2147/opth.s419857

Source records